FDA Expands Approval of GSK’s Respiratory Syncytial Virus Vaccine
Favicon 
yubnub.news

FDA Expands Approval of GSK’s Respiratory Syncytial Virus Vaccine

The logo of the British multinational pharmaceutical company GlaxoSmithKline on top of its headquarters in London on Feb. 2, 2022. Justin Tallis/AFP via Getty ImagesU.S. regulators have expanded the approval…